Scientific board

The main function of the Board is to assist Destination Santé with the scientific processing of information and to advise it, where appropriate, on the content of public health messages. The Board must issue opinions on the editorial relevance and scientific quality of the information disseminated by the various media Destination Santé is feeding. It also monitors ethics and the objective nature of the information provided by the Agency.

The Board members :
  • Take part in validating editorial decisions, assisting the Destination Santé management in defining its editorial options in line with major public health themes.
  • Enrich the choice of subjects by the Editor by broadening the scope thanks to their experience and knowledge of needs, for instance local needs.
  • Can take up any issue dealt with or broadcast by the Agency and issue comments on its relevance, scientific objectivity or quality.
  • The Editorial team may, on an ad hoc basis, call upon the members in order to benefit from their expertise or to identify a person capable of answering specific questions relating to topical events.
  • The members are full members of the Jury responsible each year for awarding the Destination Santé Prize for Mobilisation in Public Health. In this connection, they are asked to produce an opinion, giving reasons, on the applicants for this prize. They then vote to choose the prizewinner or prizewinners.
Membership of the Board :

The members are chosen – in France and elsewhere – for their academic and professional qualifications and for the guarantee of objectivity which they provide. Their expertise covers as wide a range as possible of health information topics. They are invited to join the Board for one-year periods which may be renewed. The meetings are confidential. The members take part in the meetings quite independently, contributing their scientific and personal expertise.

Dr André Prost, President of the Scientific Board

The former WHO Director responsible for Relations with Governments and the Private Sector, Dr André Prost is now a director of the GAVI Fund Affiliates which finances the operations of GAVI in 73 countries, including the least developed. André Prost is a graduate in Epidemiology at the Institut Pasteur in Paris. He was also the WHO representative to the European Union for many years.

Dr Prost is a senior official and renowned epidemiologist. At the WHO, he successively occupied the posts of Epidemiologist within the Environment Division (1985-1989), of Assistant to the Deputy Director General (1989-1992) and of Director of the Division of non-communicable diseases (1998-1999). He worked in China, Thailand and Ghana for the World Bank. A field worker, he served five years as a rural doctor for the Ministry of Health in Haute-Volta (now Burkina Faso). He also carried out a number of epidemiological evaluations throughout the world, in particular the one under the programme to combat onchocerciasis in the Volta basin (1975-1981). He regularly cooperates in the Master’s course on epidemiology at Paris VI University, in the Humanitarian Education Programme of the University of Geneva and in the Public Health Ophthalmology Course in Rabat, Morocco. He has also been a Member of the National Committee for coordinating Research on Development under the French Ministry of Research. From 1996 to 2002, he took part in Switzerland in the Steering Committee for qualitative Health planning in the Canton of Geneva. Lastly, he is the author and co-author of over 100 scientific publications.http://www.gavialliance.org.

Pr Abdelhamid Aberkane

Head of the intensive care section of the CHU Benbadis hospital in Constantine, Pr Abdelhamid Aberkane was Minister of Health and Hospital Reform in Algeria from 2001 to 2003. A mayor, member of parliament and a senator, he has chaired the National Algerian Council of Academic Ethics since 2005.

A former President of the WHO Executive Council (1998), Minister of Higher Education (1988-1989), and Dean of the Faculty of Medicine of Constantine (1970-1974), he is one of the most renowned public health specialists. He has devoted himself for many years to intensive care, training and research. Trained in the biggest French hospitals, he took part in the reform of higher education in 1970 and 1971 which provided a powerful stimulant to Algerian universities. In 1985 he co-founded the Algerian Society of Anaesthesia, Intensive Care and Emergency Care (SAARSIU). In 1991 he founded the Algerian Journal of Medicine and set up the first “Town Health” Association in Algeria. This Town Health Association in Khroub organises community health and is involved in providing health information, education and communication. It has contributed to the establishment of the Khroub Community Health Centre, the only one of its kind to date in Algeria.

Pr Michel Farnier

An internationally renowned expert, Michel Farnier is a Doctor of Medicine and Graduate of the University of Dijon. In 1986, he obtained a diploma in Human Biology, in Clinical Pharmacology and in Pharmacokinetics. The same year he specialised in Endocrinology and Nutritional diseases, also at the University of Dijon.

He currently manages the “Point medical”, a private clinic in Dijon. A researcher and teacher, he has been interested for a long time in dyslipemia and, in particular, the genetic aspects of it. He has also conducted major research into type II diabetes and the development of new cholesterol lowering agents. He is the author and co-author of 74 scientific publications, a number of which are particularly renowned.

Pr Jean-Paul Giroud

A member of the National Academy of Medicine, of the Committee for the Authorisation of Medical Products, of the Pharmacovigilance Committee and an expert with the WHO, Pr Jean-Paul Giroud is one of the most renowned specialists in pharmacology.

He has also published twelve scientific works on clinical pharmacology and inflammatory pathologies. Moreover, he is one of the authors of the famous Guide Giroud-Hagège on medical products, which is the most important reference as regards information for the general public. A Doctor of Medicine at the Paris Faculty and a Doctor of Philosophy at London University, he was Director of Research Units at the CNRS from 1974 to 2002. In particular he worked on inflammation and its mediators, as well as on cellular and molecular pharmacology. From 1970 to 2002, he was head of the Clinical Pharmacology Unit at Cochin university hospital in Paris.

Marc Gombeaud

Founder and Editor-in-Chief of Destination Santé, Marc Gombeaud has been a medical journalist since 1970 for the general public and health professionals. In particular at the Agence Centrale de Presse (ACP) (1970-84) and at the Quotidien du Médecin (1978-87).

A former Regional Adviser, Communication and Public Affairs at the WHO Regional Office for Europe, he worked for the fifty-one countries in the Region. On his return to France, he developed the concept of Destination Santé. He was both Vice-President (1977-85) and then President (1987-91) of the National Association of Medical Information Journalists (ANJIM). Since his departure from the WHO he has remained close to it: • training decision-makers, health professionals and journalists in Europe and Central Asia; • training officials in developing countries in public health crisis communication (WHO Bureau in Lyon). And of course, for over six years, he has been producing radio programmes for the WHO in French and then in Arabic, under the Destination Santé name…

Pr Yves Maugars

A University Professor and Hospital Practitioner (PUPH), Yves Maugars has headed the Rheumatology unit of the Nantes University Hospital since 1999. A graduate of the Nantes Faculty of Medicine, he is also a graduate of Chiropody and has a DEA diploma in Bio-mechanics and Bio-materials.

Osteoporosis is one of his main centres of interest, specifically osteoporosis caused by anorexia nervosa, and also absorptiometry. A member of several scientific societies – French Rheumatology Society (SFR), French Antirheumatic Association (AFLAR), Research and Information Group on Osteoporosis (GRIO) and the American Society for Bone and Mineral Research (ASBMR), he is also involved in interventional rheumatology such as complex and profound infiltrations, fragmentation and calcification of the shoulder … Yves Maugars is also director of the Continuing medical Training and Development (FMC) at the Nantes Faculty of Medicine. He regularly organises FMC sessions at both regional and national levels.

Our previous stories